SCHEMBL211008

SCHEMBL211008

CC(C)(C)OC(=O)NC1CCCN(C(=O)c2ccc(-c3cc(Cl)c(CC4CCN(C5CCCCC5)C4=O)c(Cl)c3)cc2)C1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1L1 Q9UHC9 3/20 0.42
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
PADI4 Q9UM07 4/20 0.39
USP30 Q70CQ3 1/20 0.39
BTK Q06187 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NAMPT P43490 1/20 0.36
CFTR P13569 1/20 0.35
ACLY P53396 1/20 0.35
BRD4 O60885 1/20 0.35
FPR2 P25090 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2721838 0.92 NAMPT (0.44) NPC1L1KMT2AMEN1L3MBTL1NAMPT
SCHEMBL210630 0.84 KMT2A (0.48) NPC1L1HDAC4KMT2AMEN1FPR2
SCHEMBL15216419 0.84 EPHX2 (0.42) KMT2AMEN1
SCHEMBL210606 0.82 HSD11B1 (0.46) KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL208807 0.82 HSD11B1 (0.46) KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL208680 0.82 HSD11B1 (0.46) KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL2721045 0.82 HSD11B1 (0.41) PADI4
SCHEMBL209051 0.81 HDAC4 (0.47) USP30HDAC4HDAC6KMT2AALDH1A1
SCHEMBL14391383 0.81 ALDH1A1 (0.37) KMT2AMEN1ALDH1A1CNR2FPR2
SCHEMBL209353 0.80 HSD11B1 (0.37) USP30KMT2AMEN1ALDH1A1FPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 NPC1L1 1280/4885CA1 491/4885CA2 2513/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.